ReviewFrontiers in public health2026
AI based rehabilitation: the way forward in addressing unmet needs in musculoskeletal disease.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Musculoskeletal (MSK) conditions are the leading cause of disability worldwide and, in European Union countries, account for up to 17% of years lived with disability and around 2% of gross domestic product (GDP) in direct and indirect costs. Despite universal health coverage and a doubling of public rehabilitation prescriptions in the past decade, unmet rehabilitation needs persist in Portugal, alongside growing regional disparities, long waiting times, and a heavy reliance on private services for physical rehabilitation. These factors undermine both clinical and economic outcomes. International and national evidence indicates that rehabilitation delivered through AI-enabled programmes is feasible and potentially effective, can be deployed at scale, and may reduce barriers related to geography, scheduling, and limited rehabilitation facilities. Such solutions may help improve continuity of care, shorten waiting times, and address unmet needs, but large-scale adoption requires robust frameworks for clinical evaluation and validation, patient selection, professional training, and outcome monitoring, often within hybrid models of care. By explicitly addressing potential benefits, risks, limitations, and clinical criteria, the rehabilitation community can facilitate responsible and ethical integration of AI-supported and digital models into rehabilitation practice and research, while managing the organisational and cultural changes needed to incorporate these models as complementary interventions within health systems. Drawing on WHO and OECD recommendations and on recent Portuguese implementation experience, this perspective examines how AI-driven rehabilitation may support more equitable, timely, and efficient responses to MSK rehabilitation needs, particularly for physician-prescribed care delivered under medical supervision in the home setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.